Clinical Impact of Ceftriaxone Resistance in Escherichia coli Bloodstream Infections: A Multicenter Prospective Cohort Study

BACKGROUND: Ceftriaxone-resistant (CRO-R) Escherichia coli bloodstream infections (BSIs) are common. METHODS: This is a prospective cohort of patients with E coli BSI at 14 United States hospitals between November 2020 and April 2021. For each patient with a CRO-R E coli BSI enrolled, the next conse...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamma, Pranita D, Komarow, Lauren, Ge, Lizhao, Garcia-Diaz, Julia, Herc, Erica S, Doi, Yohei, Arias, Cesar A, Albin, Owen, Saade, Elie, Miller, Loren G, Jacob, Jesse T, Satlin, Michael J, Krsak, Martin, Huskins, W Charles, Dhar, Sorabh, Shelburne, Samuel A, Hill, Carol, Baum, Keri R, Bhojani, Minal, Greenwood-Quaintance, Kerryl E, Schmidt-Malan, Suzannah M, Patel, Robin, Evans, Scott R, Chambers, Henry F, Fowler, Vance G, van Duin, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9645644/
https://www.ncbi.nlm.nih.gov/pubmed/36381622
http://dx.doi.org/10.1093/ofid/ofac572

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9645644/
https://www.ncbi.nlm.nih.gov/pubmed/36381622
http://dx.doi.org/10.1093/ofid/ofac572

Ejemplares similares